FDA Oncology Products Office Reorganization Keeps Leadership Intact

Restructuring of FDA's oncology product review divisions will not include an upheaval in leadership

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet